Carnitine-acylcarnitine translocase deficiency

MONDO:0008918

Carnitine-acylcarnitine translocase (CACT) deficiency is a life-threatening, inherited disorder of fatty acid oxidation which usually presents in the neonatal period with severe hypoketotic hypoglycemia, hyperammonemia, cardiomyopathy and/or arrhythmia, hepatic dysfunction, skeletal muscle weakness, and encephalopathy.

Also known as: CACT deficiency, carnitine-acylcarnitine translocase deficiency, CACTD, CARNITINE-acylcarnitine translocase deficiency, Cact deficiency

37 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Broader categories

Sort by